Boosting In-Vivo Anti-Tumor Immunity with an Oral Microparticulate Breast Cancer Vaccine and Low-Dose Cyclophosphamide

Tumor cells express antigens that should induce immune-mediated rejection; however, spontaneous rejection of established tumors is rare. Recent evidence suggests that patients suffering from cancer exhibit an elevation in regulatory T cells population, a subset of CD4+ T cells, which suppress tumor...

Descripción completa

Detalles Bibliográficos
Autores principales: Mulla, Nihal, Chablani, Lipika, Parenky, Ashwin C., D’Souza, Martin J.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2023
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10057030/
https://www.ncbi.nlm.nih.gov/pubmed/36992127
http://dx.doi.org/10.3390/vaccines11030543

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10057030/
https://www.ncbi.nlm.nih.gov/pubmed/36992127
http://dx.doi.org/10.3390/vaccines11030543

Ejemplares similares